CDK7 inhibitors are being investigated as anti-cancer drugs (Sava et al., 2020; Wang et al., 2020; Liang et al., 2021), and CDK12/13 inhibitors are used in the treatment of a variety of cancers (Tadesse et al., 2021). Here, CDK12 is linked to cancer.